CannaPharmaRx Inc
OTC:CPMD

Watchlist Manager
CannaPharmaRx Inc Logo
CannaPharmaRx Inc
OTC:CPMD
Watchlist
Price: 0.005 USD
Market Cap: 3.3m USD

CannaPharmaRx Inc
Net Issuance of Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

CannaPharmaRx Inc
Net Issuance of Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
CannaPharmaRx Inc
OTC:CPMD
Net Issuance of Debt
$1.9m
CAGR 3-Years
38%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Net Issuance of Debt
-$323m
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Canopy Growth Corp
TSX:WEED
Net Issuance of Debt
-CA$347.2m
CAGR 3-Years
-563%
CAGR 5-Years
-129%
CAGR 10-Years
N/A
Sundial Growers Inc
NASDAQ:SNDL
Net Issuance of Debt
-CA$39.2m
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Net Issuance of Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
Net Issuance of Debt
CA$40.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

CannaPharmaRx Inc
Glance View

Market Cap
3.3m USD
Industry
Pharmaceuticals

CannaPharmaRx, Inc. engages in the research and manufacture of cannabinoid-based pharmaceuticals. The company is headquartered in Calgary, Alberta and currently employs 4 full-time employees. The principal activity of the Company is to negotiate, acquire and develop various cannabis cultivation projects throughout Canada. The firm's activities is centered around projects, such as the Great Northern Project, and the acquisition of Ramon Road Production Campus LLC. The firm is focused on producing wholesale cannabis and hemp for the medical market.

CPMD Intrinsic Value
0.004 USD
Overvaluation 15%
Intrinsic Value
Price

See Also

What is CannaPharmaRx Inc's Net Issuance of Debt?
Net Issuance of Debt
1.9m USD

Based on the financial report for Jun 30, 2025, CannaPharmaRx Inc's Net Issuance of Debt amounts to 1.9m USD.

What is CannaPharmaRx Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
-11%

Over the last year, the Net Issuance of Debt growth was -19%. The average annual Net Issuance of Debt growth rates for CannaPharmaRx Inc have been 38% over the past three years , -11% over the past five years .

Back to Top